[en] BACKGROUND: The optimal timing of intervention in patients with asymptomatic severe aortic stenosis (AS) remains controversial. OBJECTIVES: This multicenter study sought to test and validate the prognostic value of the staging of cardiac damage in patients with asymptomatic moderate to severe AS. METHODS: This study retrospectively analyzed the clinical, Doppler echocardiographic, and outcome data that were prospectively collected in 735 asymptomatic patients (71 +/- 14 years of age; 60% men) with at least moderate AS (aortic valve area <1.5 cm(2)) and preserved left ventricular ejection fraction (>/=50%) followed in the heart valve clinics of 4 high-volume centers. Patients were classified according to the following staging classification: no cardiac damage associated with the valve stenosis (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or right ventricular damage or subclinical heart failure (Stage 4). The primary endpoint was all-cause mortality. RESULTS: At baseline, 89 (12%) patients were classified in Stage 0, 200 (27%) in Stage 1, 341 (46%) in Stage 2, and 105 (14%) in Stage 3 or 4. Median follow-up was 2.6 years (interquartile range: 1.1 to 5.2 years). There was a stepwise increase in mortality rates according to staging: 13% in Stage 0, 25% in Stage 1, 44% in Stage 2, and 58% in Stages 3 to 4 (p < 0.0001). The staging was significantly associated with excess mortality in multivariable analysis adjusted for aortic valve replacement as a time-dependent variable (hazard ratio: 1.31 per each increase in stage; 95% CI: 1.06 to 1.61; p = 0.01), and showed incremental value to several clinical variables (net reclassification index = 0.34; p = 0.003). CONCLUSIONS: The new staging system characterizing the extra-aortic valve cardiac damage provides incremental prognostic value in patients with asymptomatic moderate to severe AS. This staging classification may be helpful to identify asymptomatic AS patients who may benefit from elective aortic valve replacement.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Tastet, Lionel
Tribouilloy, Christophe
Marechaux, Sylvestre
Vollema, E. Mara
Delgado, Victoria
Salaun, Erwan
Shen, Mylene
Capoulade, Romain
Clavel, Marie-Annick
Arsenault, Marie
Bedard, Elisabeth
Bernier, Mathieu
Beaudoin, Jonathan
Narula, Jagat
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
Baumgartner, H., Falk, V., Bax, J.J., et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease: the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38 (2017), 2739–2791.
Généreux, P., Stone, G.W., O'Gara, P.T., et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 67 (2016), 2263–2288.
Lim, W.Y., Ramasamy, A., Lloyd, G., Bhattacharyya, S., Meta-analysis of the impact of intervention versus symptom-driven management in asymptomatic severe aortic stenosis. Heart 103 (2017), 268–272.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), e57–e185.
Chin, C.W., Everett, R.J., Kwiecinski, J., et al. Myocardial fibrosis and cardiac decompensation in aortic stenosis. J Am Coll Cardiol Img 10 (2017), 1320–1333.
Généreux, P., Pibarot, P., Redfors, B., et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 38 (2017), 3351–3358.
Lancellotti, P., Rosenhek, R., Pibarot, P., et al. ESC Working Group on Valvular Heart Disease position paper–heart valve clinics: organization, structure, and experiences. Eur Heart J 34 (2013), 1597–1606.
Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.
Nagueh, S.F., Smiseth, O.A., Appleton, C.P., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (2016), 277–314.
Capoulade, R., Le Ven, F., Clavel, M.A., et al. Echocardiographic predictors of outcomes in adults with aortic stenosis. Heart 102 (2016), 934–942.
Dahl, J.S., Eleid, M.F., Michelena, H.I., et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging, 8, 2015, e002917.
Taniguchi, T., Morimoto, T., Shiomi, H., et al. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis. J Am Coll Cardiol Intv 11 (2018), 145–157.
Ito, S., Miranda, W.R., Nkomo, V.T., et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol 71 (2018), 1313–1321.
Rudski, L.G., Lai, W.W., Afilalo, J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23 (2010), 685–713.
Cremer, P.C., Zhang, Y., Alu, M., et al. The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA. Eur Heart J 39 (2018), 2659–2667.
Magne, J., Cosyns, B., Popescu, B.A., et al. Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis. J Am Coll Cardiol Img 12 (2019), 84–92.
Eleid, M.F., Sorajja, P., Michelena, H.I., Malouf, J.F., Scott, C.G., Pellikka, P.A., Survival by stroke volume index in patients with low-gradient normal EF severe aortic stenosis. Heart 101 (2015), 23–29.
Dayan, V., Vignolo, G., Magne, J., Clavel, M.A., Mohty, D., Pibarot, P., Outcome and impact of aortic valve replacement in patients with preserved LV ejection fraction and low gradient aortic stenosis: a meta-analysis. J Am Coll Cardiol 66 (2015), 2594–2603.
Rusinaru, D., Bohbot, Y., Ringle, A., Maréchaux, S., Diouf, M., Tribouilloy, C., Impact of low stroke volume on mortality in patients with severe aortic stenosis and preserved left ventricular ejection fraction. Eur Heart J 39 (2018), 1992–1999.
Kang, D.H., Park, S.J., Rim, J.H., et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 121 (2010), 1502–1509.
Taniguchi, T., Morimoto, T., Shiomi, H., et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 66 (2015), 2827–2838.
Lancellotti, P., Donal, E., Magne, J., et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart 96 (2010), 1364–1371.
Lancellotti, P., Magne, J., Dulgheru, R., et al. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol 3 (2018), 1060–1068.
Hachicha, Z., Dumesnil, J.G., Bogaty, P., Pibarot, P., Paradoxical low flow, low gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115 (2007), 2856–2864.
Lancellotti, P., Magne, J., Donal, E., et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 126 (2012), 851–859.
Yang, H., Negishi, K., Wang, Y., Nolan, M., Marwick, T.H., Imaging-guided cardioprotective treatment in a community elderly population of stage B heart failure. J Am Coll Cardiol Img 10 (2017), 217–226.
Otto, C.M., Burwash, I.G., Legget, M.E., et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95 (1997), 2262–2270.
Rosenhek, R., Klaar, U., Schemper, M., et al. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J 25 (2004), 199–205.
